4.7 Article

Bioprinting of dual ECM scaffolds encapsulating limbal stem/progenitor cells in active and quiescent statuses

期刊

BIOFABRICATION
卷 13, 期 4, 页码 -

出版社

IOP PUBLISHING LTD
DOI: 10.1088/1758-5090/ac1992

关键词

DLP-based bioprinting; limbal stem cell; stem cell quiescence; endogenous stem cell; hyaluronic acid; regenerative medicine

资金

  1. National Institutes of Health (NIH) [P30 NS047101]
  2. NIH [R21EY031122, R01EB02185, R01EY021797]
  3. National Science Foundation (NSF) [1937653]
  4. California Institute for Regenerative Medicine [CLIN1-08686, CLIN2-11650]
  5. NSF [DGE-1650112]

向作者/读者索取更多资源

The study utilized bioprinting to fabricate hydrogel scaffolds encapsulating stem cells, investigating the impact of cell-extracellular matrix interaction on LSC phenotypes.
Limbal stem cell deficiency and corneal disorders are among the top global threats for human vision. Emerging therapies that integrate stem cell transplantation with engineered hydrogel scaffolds for biological and mechanical support are becoming a rising trend in the field. However, methods for high-throughput fabrication of hydrogel scaffolds, as well as knowledge of the interaction between limbal stem/progenitor cells (LSCs) and the surrounding extracellular matrix (ECM) are still much needed. Here, we employed digital light processing (DLP)-based bioprinting to fabricate hydrogel scaffolds encapsulating primary LSCs and studied the ECM-dependent LSC phenotypes. The DLP-based bioprinting with gelatin methacrylate (GelMA) or hyaluronic acid glycidyl methacrylate (HAGM) generated microscale hydrogel scaffolds that could support the viability of the encapsulated primary rabbit LSCs (rbLSCs) in culture. Immunocytochemistry and transcriptional analysis showed that the encapsulated rbLSCs remained active in GelMA-based scaffolds while exhibited quiescence in the HAGM-based scaffolds. The primary human LSCs encapsulated within bioprinted scaffolds showed consistent ECM-dependent active/quiescent statuses. Based on these results, we have developed a novel bioprinted dual ECM 'Yin-Yang' model encapsulating LSCs to support both active and quiescent statues. Our findings provide valuable insights towards stem cell therapies and regenerative medicine for corneal reconstruction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Engineering, Biomedical

Rapid bioprinting of conjunctival stem cell micro-constructs for subconjunctival ocular injection

Zheng Zhong, Xiaoqian Deng, Pengrui Wang, Claire Yu, Wisarut Kiratitanaporn, Xiaokang Wu, Jacob Schimelman, Min Tang, Alis Balayan, Emmie Yao, Jing Tian, Luwen Chen, Kang Zhang, Shaochen Chen

Summary: This study developed a rapid expansion method for conjunctival stem cells and utilized bioprinting to create hydrogel micro-constructs loaded with these cells for injectable delivery. The findings demonstrate a promising approach for the development of stem cell therapies for ocular surface diseases.

BIOMATERIALS (2021)

Article Chemistry, Multidisciplinary

Rapid 3D Bioprinting of Glioblastoma Model Mimicking Native Biophysical Heterogeneity

Min Tang, Shashi Kant Tiwari, Kriti Agrawal, Matthew Tan, Jason Dang, Trevor Tam, Jing Tian, Xueyi Wan, Jacob Schimelman, Shangting You, Qinghui Xia, Tariq M. Rana, Shaochen Chen

Summary: This study developed biomimetic tri-regional GBM models to study tumor cell behaviors and angiogenic potentials by mimicking tumor regions, acellular ECM regions, and an endothelial region with different stiffness levels.
Review Toxicology

3D bioprinting of complex tissues in vitro: state-of-the-art and future perspectives

Yi Xiang, Kathleen Miller, Jiaao Guan, Wisarut Kiratitanaporn, Min Tang, Shaochen Chen

Summary: This article introduces the application of 3D bio-printing technology in modeling complex human tissues. By controlling factors such as cell population, extracellular matrix, microenvironment, and microstructure, 3D bio-printing technology plays an important role in pharmacology and toxicology research. The article also mentions recent advancements in printing techniques and bio-ink sources, as well as specialized research in the fields of cancer, heart, muscle, and liver.

ARCHIVES OF TOXICOLOGY (2022)

Article Engineering, Biomedical

Compensating the cell-induced light scattering effect in light-based bioprinting using deep learning

Jiaao Guan, Shangting You, Yi Xiang, Jacob Schimelman, Jeffrey Alido, Xinyue Ma, Min Tang, Shaochen Chen

Summary: Digital light processing (DLP)-based 3D printing technology shows advantages in speed and precision for tissue engineering and regenerative medicine. However, the light scattering effect of cells in the bioink poses challenges for DLP-based bioprinting, requiring trial-and-error efforts for parameter optimization to compensate the scattering effects.

BIOFABRICATION (2022)

Article Engineering, Biomedical

Rapid 3D bioprinting of a multicellular model recapitulating pterygium microenvironment

Zheng Zhong, Jing Wang, Jing Tian, Xiaoqian Deng, Alis Balayan, Yazhi Sun, Yi Xiang, Jiaao Guan, Jacob Schimelman, Henry Hwang, Shangting You, Xiaokang Wu, Chao Ma, Xiaoao Shi, Emmie Yao, Sophie X. Deng, Shaochen Chen

Summary: In this study, a 3D multicellular in vitro pterygium model was developed using a digital light processing (DLP)-based 3D bioprinting platform. The model consisted of human conjunctival stem cells (hCjSCs), immune cells, and vascular cells, and showed distinct gene expression patterns related to inflammation, angiogenesis, and epithelial mesenchymal transition. The model was validated with patient-derived pterygium tissues, demonstrating its potential for personalized medicine and drug screening.

BIOMATERIALS (2022)

Article Cardiac & Cardiovascular Systems

Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction

Geoffrey de Couto, Thassio Mesquita, Xiaokang Wu, Alex Rajewski, Feng Huang, Akbarshakh Akhmerov, Na Na, Di Wu, Yizhou Wang, Liang Li, My Tran, Peter Kilfoil, Eugenio Cingolani, Eduardo Marban

Summary: This study suggests that inflammation plays a significant role in endothelial dysfunction in HFpEF. CDCs, heart-derived cell products, have been proven to have anti-inflammatory therapeutic properties. Infusion of CDCs reduces oxidative stress, restores eNOS levels, decreases monocyte levels, and restores the expression of multiple disease-associated genes, thus improving vascular reactivity. The beneficial effects of CDCs support the hypothesis that inflammation of endothelial cells is a major driver of HFpEF.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2022)

Article Cell Biology

Global Transcriptional and Epigenetic Reconfiguration during Chemical Reprogramming of Human Retinal Pigment Epithelial Cells into Photoreceptor-like Cells

Xiaoqian Deng, Ryan Lee, Sin Yee Lim, Zheng Zhong, Jing Wang, Yizhi Liu, Guoping Fan

Summary: In this study, human fetal retinal pigment epithelial (RPE) cells were successfully reprogrammed into photoreceptor-like cells through the use of small molecules, providing a potential cell source for cell replacement therapy in retinal degenerative diseases. The suppression of epithelial-to-mesenchymal transition and activation of glutamate receptors were found to be important mechanisms in the conversion process.
Article Medicine, Research & Experimental

Inhibitory effect of lanosterol on cataractous lens of cynomolgus monkeys using a subconjunctival drug release system

Keke Zhang, Wenwen He, Yu Du, Yugui Zhou, Xiaokang Wu, Jie Zhu, Xiangjia Zhu, Kang Zhang, Yi Lu

Summary: The effect of lanosterol on cataract progression was evaluated in vivo models of primates. Lanosterol showed a short-term and reliable reversal effect on reducing cataract severity in cortical cataract in the early stages, possibly due to the increase in the solubility of lens proteins and changes in the oxidative stress status. Lanosterol administration using subconjunctival drug release system could be a promising nonsurgical approach for future clinical studies of cataract prevention and treatment.

PRECISION CLINICAL MEDICINE (2022)

暂无数据